Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Quantum Biopharma (QNTM) Assets Average (2022 - 2025)

Quantum Biopharma's Assets Average history spans 3 years, with the latest figure at $12.7 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 29.97% to $12.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.7 million, a 29.97% decrease, with the full-year FY2025 number at $14.1 million, down 18.25% from a year prior.
  • Assets Average hit $12.7 million in Q4 2025 for Quantum Biopharma, down from $14.7 million in the prior quarter.
  • Over the last five years, Assets Average for QNTM hit a ceiling of $63.0 million in Q1 2022 and a floor of $12.7 million in Q4 2025.
  • Historically, Assets Average has averaged $33.3 million across 3 years, with a median of $17.6 million in 2024.
  • The widest YoY moves for Assets Average: up 14.07% in 2025, down 29.97% in 2025.
  • Tracing QNTM's Assets Average over 3 years: stood at $50.7 million in 2022, then tumbled by 64.34% to $18.1 million in 2024, then decreased by 29.97% to $12.7 million in 2025.
  • Business Quant data shows Assets Average for QNTM at $12.7 million in Q4 2025, $14.7 million in Q3 2025, and $15.1 million in Q2 2025.